LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 68

Search options

  1. Article ; Online: Editorial overview: Musculoskeletal: Are we on the road to personalised medicine in musculoskeletal diseases?

    Gartland, Alison / Hocking, Lynne J

    Current opinion in pharmacology

    2014  Volume 16, Page(s) vii–ix

    MeSH term(s) Animals ; Humans ; MicroRNAs ; Musculoskeletal Diseases/drug therapy ; Musculoskeletal Diseases/genetics ; Musculoskeletal Diseases/metabolism ; Precision Medicine ; Receptors, Purinergic/metabolism
    Chemical Substances MicroRNAs ; Receptors, Purinergic
    Language English
    Publishing date 2014-06
    Publishing country England
    Document type Editorial ; Introductory Journal Article
    ZDB-ID 2037057-X
    ISSN 1471-4973 ; 1471-4892
    ISSN (online) 1471-4973
    ISSN 1471-4892
    DOI 10.1016/j.coph.2014.06.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Stratified medicine approaches for the treatment of musculoskeletal disorders.

    Hocking, Lynne J / Rivadeneira, Fernando

    Current opinion in pharmacology

    2014  Volume 16, Page(s) 127–132

    Abstract: Stratified medicine approaches for the treatment of musculoskeletal disorders offer opportunities to effectively target interventions to those individuals who will gain most benefit from them and minimise adverse side effects. Such approaches have been ... ...

    Abstract Stratified medicine approaches for the treatment of musculoskeletal disorders offer opportunities to effectively target interventions to those individuals who will gain most benefit from them and minimise adverse side effects. Such approaches have been the 'holy grail' of a variety of research fields spanning epidemiological, (epi)genetic, transcriptomic, proteomic and imaging biomarkers that predict disease diagnosis, prognosis or response to treatment. In this review, we highlight the successes and opportunities for stratified medicine approaches across a range of musculoskeletal disorders, with a focus on genetic risk factors, since these are the most stable across the lifetime of each individual.
    MeSH term(s) Biomarkers ; Humans ; Musculoskeletal Diseases/drug therapy ; Musculoskeletal Diseases/genetics ; Musculoskeletal Diseases/metabolism
    Chemical Substances Biomarkers
    Language English
    Publishing date 2014-06-02
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2037057-X
    ISSN 1471-4973 ; 1471-4892
    ISSN (online) 1471-4973
    ISSN 1471-4892
    DOI 10.1016/j.coph.2014.05.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Genetics and aetiology of Pagetic disorders of bone.

    Helfrich, Miep H / Hocking, Lynne J

    Archives of biochemistry and biophysics

    2008  Volume 473, Issue 2, Page(s) 172–182

    Abstract: Paget's disease of bone (PDB) is a late-onset disorder characterised by focal areas of increased bone turnover containing enlarged hyperactive osteoclasts. The disease has a strong genetic predisposition and mutations in SQSTM1 have been associated with ... ...

    Abstract Paget's disease of bone (PDB) is a late-onset disorder characterised by focal areas of increased bone turnover containing enlarged hyperactive osteoclasts. The disease has a strong genetic predisposition and mutations in SQSTM1 have been associated with familial and sporadic disease in up to 40% of cases. Additional genetic loci have been associated in other cases, but genes are yet to be identified. Earlier-onset conditions with similar bone pathology (familial expansile osteolysis, expansile skeletal hyperphosphatasia and early-onset PDB) are caused by mutations in TNFRSF11A (RANK). The syndrome of inclusion body myositis, Paget's disease and frontotemporal dementia is caused by mutations in VCP. Despite the increased knowledge about genes involved in PDB and related disorders, the etiology of the diseases remains puzzling. Presence of inclusion bodies appears to link Pagetic diseases mechanistically to diseases associated with presence of misfolded proteins or abnormalities in the ubiquitin-proteasomal, or autophagy pathways. Juvenile PDB, caused by osteoprotegerin deficiency, appears mechanistically distinct from the other Pagetic diseases. This review will discuss evidence from recent studies, including new animal models for Pagetic diseases.
    MeSH term(s) Adaptor Proteins, Signal Transducing/genetics ; Adaptor Proteins, Signal Transducing/metabolism ; Adenosine Triphosphatases/genetics ; Adenosine Triphosphatases/metabolism ; Animals ; Cell Cycle Proteins/genetics ; Cell Cycle Proteins/metabolism ; Genetic Predisposition to Disease ; Humans ; Inclusion Bodies/pathology ; Mutation ; Osteitis Deformans/genetics ; Osteitis Deformans/pathology ; Osteoclasts/metabolism ; Osteoclasts/pathology ; Osteoprotegerin/deficiency ; Receptor Activator of Nuclear Factor-kappa B/genetics ; Receptor Activator of Nuclear Factor-kappa B/metabolism ; Sequestosome-1 Protein ; Valosin Containing Protein
    Chemical Substances Adaptor Proteins, Signal Transducing ; Cell Cycle Proteins ; Osteoprotegerin ; Receptor Activator of Nuclear Factor-kappa B ; SQSTM1 protein, human ; Sequestosome-1 Protein ; TNFRSF11A protein, human ; Adenosine Triphosphatases (EC 3.6.1.-) ; VCP protein, human (EC 3.6.4.6) ; Valosin Containing Protein (EC 3.6.4.6)
    Language English
    Publishing date 2008-05-15
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 523-x
    ISSN 1096-0384 ; 0003-9861
    ISSN (online) 1096-0384
    ISSN 0003-9861
    DOI 10.1016/j.abb.2008.02.045
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Autophagy: a new player in skeletal maintenance?

    Hocking, Lynne J / Whitehouse, Caroline / Helfrich, Miep H

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

    2012  Volume 27, Issue 7, Page(s) 1439–1447

    Abstract: Imbalances between bone resorption and formation lie at the root of disorders such as osteoporosis, Paget's disease of bone (PDB), and osteopetrosis. Recently, genetic and functional studies have implicated proteins involved in autophagic protein ... ...

    Abstract Imbalances between bone resorption and formation lie at the root of disorders such as osteoporosis, Paget's disease of bone (PDB), and osteopetrosis. Recently, genetic and functional studies have implicated proteins involved in autophagic protein degradation as important mediators of bone cell function in normal physiology and in pathology. Autophagy is the conserved process whereby aggregated proteins, intracellular pathogens, and damaged organelles are degraded and recycled. This process is important both for normal cellular quality control and in response to environmental or internal stressors, particularly in terminally-differentiated cells. Autophagic structures can also act as hubs for the spatial organization of recycling and synthetic process in secretory cells. Alterations to autophagy (reduction, hyperactivation, or impairment) are associated with a number of disorders, including neurodegenerative diseases and cancers, and are now being implicated in maintenance of skeletal homoeostasis. Here, we introduce the topic of autophagy, describe the new findings that are starting to emerge from the bone field, and consider the therapeutic potential of modifying this pathway for the treatment of age-related bone disorders.
    MeSH term(s) Aging ; Animals ; Autophagy/physiology ; Bone and Bones/cytology ; Bone and Bones/physiology ; Cell Differentiation ; Homeostasis ; Humans ; Immunosuppressive Agents/therapeutic use ; Mice ; Models, Biological ; Osteoblasts/cytology ; Osteoclasts/cytology ; Osteocytes/cytology ; Oxidative Stress ; Stem Cells/cytology
    Chemical Substances Immunosuppressive Agents
    Language English
    Publishing date 2012-06-16
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 632783-7
    ISSN 1523-4681 ; 0884-0431
    ISSN (online) 1523-4681
    ISSN 0884-0431
    DOI 10.1002/jbmr.1668
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Genome sequencing with gene panel-based analysis for rare inherited conditions in a publicly funded healthcare system: implications for future testing.

    Hocking, Lynne J / Andrews, Claire / Armstrong, Christine / Ansari, Morad / Baty, David / Berg, Jonathan / Bradley, Therese / Clark, Caroline / Diamond, Austin / Doherty, Jill / Lampe, Anne / McGowan, Ruth / Moore, David J / O'Sullivan, Dawn / Purvis, Andrew / Santoyo-Lopez, Javier / Westwood, Paul / Abbott, Michael / Williams, Nicola /
    Aitman, Timothy J / Miedzybrodzka, Zosia

    European journal of human genetics : EJHG

    2022  Volume 31, Issue 2, Page(s) 231–238

    Abstract: NHS genetics centres in Scotland sought to investigate the Genomics England 100,000 Genomes Project diagnostic utility to evaluate genome sequencing for in rare, inherited conditions. Four regional services recruited 999 individuals from 394 families in ... ...

    Abstract NHS genetics centres in Scotland sought to investigate the Genomics England 100,000 Genomes Project diagnostic utility to evaluate genome sequencing for in rare, inherited conditions. Four regional services recruited 999 individuals from 394 families in 200 rare phenotype categories, with negative historic genetic testing. Genome sequencing was performed at Edinburgh Genomics, and phenotype and sequence data were transferred to Genomics England for variant calling, gene-based filtering and variant prioritisation. NHS Scotland genetics laboratories performed interpretation, validation and reporting. New diagnoses were made in 23% cases - 19% in genes implicated in disease at the time of variant prioritisation, and 4% from later review of additional genes. Diagnostic yield varied considerably between phenotype categories and was minimal in cases with prior exome testing. Genome sequencing with gene panel filtering and reporting achieved improved diagnostic yield over previous historic testing but not over now routine trio-exome sequence tests. Re-interpretation of genomic data with updated gene panels modestly improved diagnostic yield at minimal cost. However, to justify the additional costs of genome vs exome sequencing, efficient methods for analysis of structural variation will be required and / or cost of genome analysis and storage will need to decrease.
    MeSH term(s) Genetic Testing ; Genomics/methods ; Phenotype ; Chromosome Mapping ; England
    Language English
    Publishing date 2022-12-06
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1141470-4
    ISSN 1476-5438 ; 1018-4813
    ISSN (online) 1476-5438
    ISSN 1018-4813
    DOI 10.1038/s41431-022-01226-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Chronic pain, depression and cardiovascular disease linked through a shared genetic predisposition: Analysis of a family-based cohort and twin study.

    van Hecke, Oliver / Hocking, Lynne J / Torrance, Nicola / Campbell, Archie / Padmanabhan, Sandosh / Porteous, David J / McIntosh, Andrew M / Burri, Andrea V / Tanaka, Haruka / Williams, Frances M K / Smith, Blair H

    PloS one

    2017  Volume 12, Issue 2, Page(s) e0170653

    Abstract: Background: Depression and chronic pain are the two most important causes of disability (Global Burden of Disease Study 2013). They occur together more frequently than expected and both conditions have been shown to be co-morbid with cardiovascular ... ...

    Abstract Background: Depression and chronic pain are the two most important causes of disability (Global Burden of Disease Study 2013). They occur together more frequently than expected and both conditions have been shown to be co-morbid with cardiovascular disease. Although shared socio-demographic risk factors (e.g. gender, deprivation) might explain the co-morbidity of these three conditions, we hypothesised that these three long-term, highly prevalent conditions co-occur and may be due to shared familial risk, and/or genetic factors.
    Methods and findings: We employed three different study designs in two independent cohorts, namely Generation Scotland and TwinsUK, having standardised, validated questionnaire data on the three traits of interest. First, we estimated the prevalence and co-occurrence of chronic pain, depression and angina among 24,024 participants of a population-based cohort of extended families (Generation Scotland: Scottish Family Health Study), adjusting for age, gender, education, smoking status, and deprivation. Secondly, we compared the odds of co-morbidity in sibling-pairs with the odds in unrelated individuals for the three conditions in the same cohort. Lastly, examination of similar traits in a sample of female twins (TwinsUK, n = 2,902), adjusting for age and BMI, allowed independent replication of the findings and exploration of the influence of additive genetic (A) factors and shared (C) and non-shared (E) environmental factors predisposing to co-occurring chronic widespread pain (CWP) and cardiovascular disease (hypertension, angina, stroke, heart attack, elevated cholesterol, angioplasty or bypass surgery). In the Generation Scotland cohort, individuals with depression were more than twice as likely to have chronic pain as those without depression (adjusted OR 2·64 [95% CI 2·34-2·97]); those with angina were four times more likely to have chronic pain (OR 4·19 [3·64-4·82]); those with depression were twice as likely to have angina (OR 2·20 [1·90-2·54]). Similar odds were obtained when the outcomes and predictors were reversed and similar effects seen among sibling pairs; depression in one sibling predicted chronic pain in the other (OR 1·34 [1·05-1·71]), angina predicted chronic pain in the other (OR 2·19 [1·63-2·95]), and depression, angina (OR 1·98 [1·49-2·65]). Individuals with chronic pain and angina showed almost four-fold greater odds of depression compared with those manifesting neither trait (OR 3·78 [2·99-4·78]); angina showed seven-fold increased odds in the presence of chronic pain and depression (OR 7·76 [6·05-9·95]) and chronic pain nine-fold in the presence of depression and angina (OR 9·43 [6·85-12·98]). In TwinsUK, the relationship between CWP and depression has been published (R = 0.34, p<0.01). Considering the CWP-cardiovascular relationship, the most suitable model to describe the observed data was a combination of A, C and E, with a small but significant genetic predisposition, shared between the two traits (2·2% [95% CI 0·06-0·23]).
    Conclusion: We found an increased co-occurrence of chronic pain, depression and cardiovascular disease in two independent cohorts (general population-based cohort, twins cohort) suggesting a shared genetic contribution. Adjustment for known environmental influences, particularly those relating to socio-economic status (Generation Scotland: age, gender, deprivation, smoking, education; Twins UK: age,BMI) did not explain the relationship observed between chronic pain, depression and cardiovascular disease. Our findings from two independent cohorts challenge the concept of traditional disease boundaries and warrant further investigation of shared biological mechanisms.
    MeSH term(s) Adult ; Aged ; Angina Pectoris/epidemiology ; Angina Pectoris/genetics ; Chronic Pain/epidemiology ; Chronic Pain/genetics ; Cohort Studies ; Comorbidity ; Depressive Disorder/epidemiology ; Depressive Disorder/genetics ; Diseases in Twins/genetics ; Female ; Genetic Predisposition to Disease ; Humans ; Male ; Middle Aged ; Pain Measurement ; Prevalence ; Surveys and Questionnaires ; Twins/genetics
    Language English
    Publishing date 2017-02-22
    Publishing country United States
    Document type Journal Article ; Twin Study
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0170653
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Bone remodelling at a glance.

    Crockett, Julie C / Rogers, Michael J / Coxon, Fraser P / Hocking, Lynne J / Helfrich, Miep H

    Journal of cell science

    2011  Volume 124, Issue Pt 7, Page(s) 991–998

    MeSH term(s) Animals ; Bone Remodeling ; Bone Resorption ; Bone and Bones/cytology ; Bone and Bones/metabolism ; Cell Differentiation ; Extracellular Matrix/metabolism ; Humans ; Osteoblasts/cytology ; Osteoblasts/metabolism ; Osteoclasts/cytology ; Osteoclasts/metabolism ; Signal Transduction
    Language English
    Publishing date 2011-03-14
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2993-2
    ISSN 1477-9137 ; 0021-9533
    ISSN (online) 1477-9137
    ISSN 0021-9533
    DOI 10.1242/jcs.063032
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Functional interaction between sequestosome-1/p62 and autophagy-linked FYVE-containing protein WDFY3 in human osteoclasts.

    Hocking, Lynne J / Mellis, David J / McCabe, Paul S / Helfrich, Miep H / Rogers, Michael J

    Biochemical and biophysical research communications

    2010  Volume 402, Issue 3, Page(s) 543–548

    Abstract: Paget's disease of bone (PDB) is a late-onset disorder characterised by focal areas of increased bone resorption, with osteoclasts that are increased in size, multinuclearity, number and activity. PDB-causing missense and nonsense variants in the gene ... ...

    Abstract Paget's disease of bone (PDB) is a late-onset disorder characterised by focal areas of increased bone resorption, with osteoclasts that are increased in size, multinuclearity, number and activity. PDB-causing missense and nonsense variants in the gene encoding Sequestosome-1/p62 (SQSTM1) have been identified, all of which cluster in and around the ubiquitin-associated (UBA) domain of the protein. SQSTM1 is ubiquitously expressed and there is, as yet, no clear reason why these mutations only appear to cause an osteoclast-related phenotype. Using co-immunoprecipitation and tandem mass spectrometry, we identified a novel interaction in human osteoclast-like cells between SQSTM1 and Autophagy-Linked FYVE domain-containing protein (ALFY/WDFY3). Endogenous ALFY and SQSTM1 both localised within the nuclei of osteoclasts and their mononuclear precursors. When osteoclasts were starved to induce autophagy, SQSTM1 and ALFY relocated to the cytoplasm where they formed large aggregates, with cytoplasmic relocalisation appearing more rapid in mature osteoclasts than in precursors in the same culture. Overexpression of wild-type SQSTM1 in HEK293 cells also resulted in the formation of cytoplasmic aggregates containing SQSTM1 and endogenous ALFY, as did overexpression of a PDB-causing missense mutant form of SQSTM1, indicating that this mutation does not impair the formation of SQSTM1- and ALFY-containing aggregates. Expression of ALFY in bone cells has not previously been reported, and the process of autophagy has not been studied with respect to osteoclast activity. We have identified a functional interaction between SQSTM1 and ALFY in osteoclasts under conditions of cell stress. The difference in response to starvation between mature osteoclasts and their precursors may begin to explain the cell-specific functional effects of SQSTM1 mutations in PDB.
    MeSH term(s) Adaptor Proteins, Signal Transducing/genetics ; Adaptor Proteins, Signal Transducing/metabolism ; Autophagy ; Cell Line ; Cell Nucleus/metabolism ; Cytoplasm/metabolism ; Humans ; Immunoprecipitation ; Membrane Proteins/metabolism ; Mutation ; Osteoclasts/metabolism ; Sequestosome-1 Protein ; Stress, Physiological ; Tandem Mass Spectrometry ; Transcription Factors/metabolism
    Chemical Substances Adaptor Proteins, Signal Transducing ; Membrane Proteins ; SQSTM1 protein, human ; Sequestosome-1 Protein ; Transcription Factors ; WDFY3 protein, human
    Language English
    Publishing date 2010-11-19
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 205723-2
    ISSN 1090-2104 ; 0006-291X ; 0006-291X
    ISSN (online) 1090-2104 ; 0006-291X
    ISSN 0006-291X
    DOI 10.1016/j.bbrc.2010.10.076
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Cardiovascular risk factors associated with the metabolic syndrome are more prevalent in people reporting chronic pain: results from a cross-sectional general population study.

    Goodson, Nicola J / Smith, Blair H / Hocking, Lynne J / McGilchrist, Mark M / Dominiczak, Anna F / Morris, Andrew / Porteous, David J / Goebel, Andreas

    Pain

    2013  Volume 154, Issue 9, Page(s) 1595–1602

    Abstract: To explore whether chronic pain is associated with cardiovascular risk factors and identify whether increased distribution or intensity of pain is associated with cardiovascular risk, participants in Generation Scotland: The Scottish Family Health study ... ...

    Abstract To explore whether chronic pain is associated with cardiovascular risk factors and identify whether increased distribution or intensity of pain is associated with cardiovascular risk, participants in Generation Scotland: The Scottish Family Health study completed pain questionnaires recording the following: presence of chronic pain, distribution of pain, and intensity of chronic pain. Blood pressure, lipids, blood glucose, smoking history, waist-hip ratio, and body mass index were recorded; Framingham 10-year coronary heart disease (CHD) risk scores were calculated and a diagnosis of metabolic syndrome derived. Associations between chronic pain and cardiovascular risk were explored. Of 13,328 participants, 1100 (8.3%) had high CHD risk. Chronic pain was reported by 5209 (39%), 1294 (9.7%) reported widespread chronic pain, and 707 (5.3%) reported high-intensity chronic pain. In age- and gender-adjusted analyses, chronic pain was associated with elevated CHD risk scores (odds ratio 1.11, 95% confidence interval 1.01-1.23) and the metabolic syndrome (odds ratio 1.42, 95% confidence interval 1.24-1.62). Multivariate analyses identified dyslipidaemia, age, gender, smoking, obesity, and high waist-hip ratio as independently associated with chronic pain. Within the chronic pain subgroup, widespread pain did not confer any additional cardiovascular disease risk. However, cardiovascular disease risk factors contributing to metabolic syndrome were more prevalent in those reporting high-intensity chronic pain. This large population-based study has demonstrated that chronic pain, and in particular high-intensity chronic pain, is associated with an increased prevalence of cardiovascular risk factors and metabolic syndrome. The 10-year CHD risk score and metabolic syndrome correlate well with increased pain intensity, but not with widespread pain.
    MeSH term(s) Adult ; Blood Glucose ; Cardiovascular Diseases/epidemiology ; Chronic Pain/diagnosis ; Chronic Pain/epidemiology ; Cohort Studies ; Community Health Planning ; Cross-Sectional Studies ; Female ; Humans ; Logistic Models ; Male ; Metabolic Diseases/epidemiology ; Middle Aged ; Odds Ratio ; Pain Measurement ; Prevalence ; Retrospective Studies ; Risk Factors ; Surveys and Questionnaires
    Chemical Substances Blood Glucose
    Language English
    Publishing date 2013-05-07
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 193153-2
    ISSN 1872-6623 ; 0304-3959
    ISSN (online) 1872-6623
    ISSN 0304-3959
    DOI 10.1016/j.pain.2013.04.043
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Investigating shared aetiology between type 2 diabetes and major depressive disorder in a population based cohort.

    Clarke, Toni-Kim / Obsteter, Jana / Hall, Lynsey S / Hayward, Caroline / Thomson, Pippa A / Smith, Blair H / Padmanabhan, Sandosh / Hocking, Lynne J / Deary, Ian J / Porteous, David J / McIntosh, Andrew M

    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics

    2016  Volume 174, Issue 3, Page(s) 227–234

    Abstract: Type II diabetes (T2D) and major depressive disorder (MDD) are often co-morbid. The reasons for this co-morbidity are unclear. Some studies have highlighted the importance of environmental factors and a causal relationship between T2D and MDD has also ... ...

    Abstract Type II diabetes (T2D) and major depressive disorder (MDD) are often co-morbid. The reasons for this co-morbidity are unclear. Some studies have highlighted the importance of environmental factors and a causal relationship between T2D and MDD has also been postulated. In the present study we set out to investigate the shared aetiology between T2D and MDD using Mendelian randomization in a population based sample, Generation Scotland: the Scottish Family Health Study (N = 21,516). Eleven SNPs found to be associated with T2D were tested for association with MDD and psychological distress (General Health Questionnaire scores). We also assessed causality and genetic overlap between T2D and MDD using polygenic risk scores (PRS) assembled from the largest available GWAS summary statistics to date. No single T2D risk SNP was associated with MDD in the MR analyses and we did not find consistent evidence of genetic overlap between MDD and T2D in the PRS analyses. Linkage disequilibrium score regression analyses supported these findings as no genetic correlation was observed between T2D and MDD (rG = 0.0278 (S.E. 0.11), P-value = 0.79). As suggested by previous studies, T2D and MDD covariance may be better explained by environmental factors. Future studies would benefit from analyses in larger cohorts where stratifying by sex and looking more closely at MDD cases demonstrating metabolic dysregulation is possible. © 2016 The Authors. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Published by Wiley Periodicals, Inc.
    MeSH term(s) Cohort Studies ; Comorbidity ; Depressive Disorder, Major/etiology ; Depressive Disorder, Major/genetics ; Diabetes Mellitus, Type 2/etiology ; Diabetes Mellitus, Type 2/genetics ; Female ; Genetic Predisposition to Disease ; Genome-Wide Association Study ; Humans ; Male ; Multifactorial Inheritance/genetics ; Polymorphism, Single Nucleotide/genetics ; Risk Assessment ; Risk Factors ; Scotland
    Language English
    Publishing date 2016-08-02
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2108616-3
    ISSN 1552-485X ; 1552-4841 ; 0148-7299
    ISSN (online) 1552-485X
    ISSN 1552-4841 ; 0148-7299
    DOI 10.1002/ajmg.b.32478
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top